BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36618423)

  • 21. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
    Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
    Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
    Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
    Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
    World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Immune Response to Tumor-Associated Antigens and Immune Cell Profile in Patients With Hepatocellular Carcinoma.
    Inada Y; Mizukoshi E; Seike T; Tamai T; Iida N; Kitahara M; Yamashita T; Arai K; Terashima T; Fushimi K; Yamashita T; Honda M; Kaneko S
    Hepatology; 2019 Feb; 69(2):653-665. PubMed ID: 30102778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice.
    Duan X; Wang M; Han X; Ren J; Huang G; Ju S; Zhang Q
    Cell Cycle; 2020 Dec; 19(24):3595-3607. PubMed ID: 33283623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation.
    Zerbini A; Pilli M; Fagnoni F; Pelosi G; Pizzi MG; Schivazappa S; Laccabue D; Cavallo C; Schianchi C; Ferrari C; Missale G
    J Immunother; 2008 Apr; 31(3):271-82. PubMed ID: 18317360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD38 marks the exhausted CD8
    Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
    Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
    Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
    J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
    Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.
    Rong D; Wang Y; Liu L; Cao H; Huang T; Liu H; Hao X; Sun G; Sun G; Zheng Z; Kang J; Xia Y; Chen Z; Tang W; Wang X
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36787938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S
    Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma.
    Huang CY; Wang Y; Luo GY; Han F; Li YQ; Zhou ZG; Xu GL
    J Immunother; 2017; 40(9):323-333. PubMed ID: 29028787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma.
    Guo D; Qin L; Sun J; Li K; Zang C; Wang Q; Qiao W; Liu B; Zhao Y; Zhang Y
    Technol Cancer Res Treat; 2023; 22():15330338231190644. PubMed ID: 37525880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma.
    Zhou Y; Xu X; Ding J; Jing X; Wang F; Wang Y; Wang P
    J Cancer Res Ther; 2018 Jan; 14(1):40-45. PubMed ID: 29516957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.